Skip to main content
Pharmaceutical product and formulation background
Animal Healthcare Division

Buparvaquone Injection

Strength: 50 mg/mL

Technical Overview

Buparvaquone Injection

Buparvaquone

Category

Anti-Protozoals

Dosage Form

Injection

Strength

50 mg/mL

Therapeutic Class

Anti-Protozoals

Product Overview

Buparvaquone Injection is a anti-protozoals formulation in injection presentation. The documented composition contains Buparvaquone.

Description

Buparvaquone Injection is a injection veterinary formulation containing Buparvaquone. The documented strength is 50 mg/mL.

Composition

Ingredient
Buparvaquone
Pharmacopoeial Standard
Standard documented on approved product literature; confirmation available on request

Strength

50 mg/mL

Specifications

Generic Name
Buparvaquone
Dosage Form
Injection
Strength
50 mg/mL

Product Inquiry

Disclaimer

Products offered are intended strictly for veterinary use, R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.

This website uses cookies to optimize your navigation and adapt to your preferences. You can continue browsing without accepting. If you select "Accept", you accept the use of ALL cookies. You can also select cookies in "Cookie settings" and consult our Cookies Policy and Privacy Policy here.